[{"indications": "Indications\u00a0see notes above and under Dose", "name": "DIPYRIDAMOLE With aspirin", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs", "DIPYRIDAMOLE", "With aspirin"], "cautions": "Cautions\u00a0rapidly worsening angina, aortic stenosis, recent\r\nmyocardial infarction, left ventricular\r\noutflow obstruction, heart failure; may exacerbate migraine; hypotension; myasthenia gravis (risk of\r\nexacerbation); coagulation disorders; concomitant use of drugs that increase risk of bleeding; interactions: Appendix 1 (dipyridamole)", "side-effects": "Side-effects\u00a0gastro-intestinal effects, dizziness, myalgia,\r\nthrobbing headache, hypotension, hot flushes and tachycardia; worsening\r\nsymptoms of coronary heart disease; hypersensitivity reactions such\r\nas rash, urticaria, severe bronchospasm and angioedema; increased\r\nbleeding during or after surgery; thrombocytopenia reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/69388.htm", "doses": ["By mouth, 300\u2013600\u00a0mg daily in 3\u20134\r\ndivided doses", "Modified-release preparations, see under preparation below", "By intravenous injection, diagnostic\r\nonly, consult product literature", "Name[Asasantin\u00ae Retard (Boehringer Ingelheim) ] Capsules, red/ivory, aspirin 25\u00a0mg, dipyridamole 200\u00a0mg (m/r), net price 60-cap\r\npack = \u00a37.79. \r\n    Label:\r\n    21, 25Dose\u00a0secondary prevention of ischaemic stroke and transient\r\nischaemic attacks, 1 capsule twice dailyNote\u00a0Dispense in original container (pack contains\r\na desiccant) and discard any capsules remaining 6 weeks after opening"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0see notes above and under Dose", "name": "DIPYRIDAMOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs", "DIPYRIDAMOLE"], "cautions": "Cautions\u00a0rapidly worsening angina, aortic stenosis, recent\r\nmyocardial infarction, left ventricular\r\noutflow obstruction, heart failure; may exacerbate migraine; hypotension; myasthenia gravis (risk of\r\nexacerbation); coagulation disorders; concomitant use of drugs that increase risk of bleeding; interactions: Appendix 1 (dipyridamole)", "side-effects": "Side-effects\u00a0gastro-intestinal effects, dizziness, myalgia,\r\nthrobbing headache, hypotension, hot flushes and tachycardia; worsening\r\nsymptoms of coronary heart disease; hypersensitivity reactions such\r\nas rash, urticaria, severe bronchospasm and angioedema; increased\r\nbleeding during or after surgery; thrombocytopenia reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2811.htm", "doses": ["By mouth, 300\u2013600\u00a0mg daily in 3\u20134\r\ndivided doses", "Modified-release preparations, see under preparation below", "By intravenous injection, diagnostic\r\nonly, consult product literature"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0see notes above and under Dose", "name": "DIPYRIDAMOLE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs", "DIPYRIDAMOLE", "Modified release"], "cautions": "Cautions\u00a0rapidly worsening angina, aortic stenosis, recent\r\nmyocardial infarction, left ventricular\r\noutflow obstruction, heart failure; may exacerbate migraine; hypotension; myasthenia gravis (risk of\r\nexacerbation); coagulation disorders; concomitant use of drugs that increase risk of bleeding; interactions: Appendix 1 (dipyridamole)", "side-effects": "Side-effects\u00a0gastro-intestinal effects, dizziness, myalgia,\r\nthrobbing headache, hypotension, hot flushes and tachycardia; worsening\r\nsymptoms of coronary heart disease; hypersensitivity reactions such\r\nas rash, urticaria, severe bronchospasm and angioedema; increased\r\nbleeding during or after surgery; thrombocytopenia reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/60544.htm", "doses": ["By mouth, 300\u2013600\u00a0mg daily in 3\u20134\r\ndivided doses", "Modified-release preparations, see under preparation below", "By intravenous injection, diagnostic\r\nonly, consult product literature", "Name[Persantin\u00ae Retard (Boehringer Ingelheim) ] Capsules, m/r, red/orange containing\r\nyellow pellets, dipyridamole 200\u00a0mg, net price\r\n60-cap pack = \u00a39.00. \r\n    Label:\r\n    21, 25Dose\u00a0secondary prevention of ischaemic stroke and transient\r\nischaemic attacks (used alone or with aspirin),\r\nadjunct to oral anticoagulation for prophylaxis of thromboembolism\r\nassociated with prosthetic heart valves, 200\u00a0mg twice daily preferably\r\nwith foodNote\u00a0Dispense in original container (pack contains\r\na desiccant) and discard any capsules remaining 6 weeks after opening"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]